DUBLIN--(BUSINESS WIRE)--The "Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. Kv1.3 Potassium Channel Blockers - Pipeline ...
The study sought to evaluate the efficacy, safety, and tolerability of azetukalner, administered as an oral, adjunctive, once ...
Mutant Brown-Norway-Katholiek (muBN-Ka) rats are capable of producing kininogens in the liver, but cannot release them into the bloodstream, because of the point mutation of Ala163 to Thr in the ...
Researchers have discovered a new mechanism for potassium channel inhibitor entry, which could improve the specificity of drugs targeting the channel. Upon binding to calcium ions, BK channels allow ...
Researchers at Semmelweis University and University of Szeged have disclosed aminoalkylated benzoxy compounds acting as potassium channel blockers reported to be useful for the treatment of atrial ...
Ibutilide is the only Food and Drug Administration-approved intravenous drug for the rapid termination of atrial fibrillation and flutter. Its mechanism of action is undecided. The drug has been ...
A health explainer details how specific foods and beverages interact with blood pressure therapy, emphasizing safety implications. It outlines interactions between grapefruit and calcium channel ...
DUBLIN--(BUSINESS WIRE)--The "Kv1.3 Potassium Channel Blockers -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. 'Kv1.3 Potassium Channel Blockers - Pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results